Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography .

Description

The global non-invasive blood glucose monitoring devices market was valued US$ 24.22 Mn in 2023 and is expected to reach US$ 77.63 Mn by 2031 growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 24.22 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	15.70%	2030/2031 Value Projection:	US$ 77.63 Mn

Figure 1. Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%), by Region, 2023

Non-Invasive Blood Glucose Monitoring Devices Market - IMG1

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

Global non-invasive blood glucose monitoring devices Market, By Technology:
- EM Waves
- Transdermal
- Optical
- Enzymatic
Global non-invasive blood glucose monitoring devices Market, By Modality:
- Wearable
- Non-wearable/Benchtop
- Embedded Devices
Global non-invasive blood glucose monitoring devices Market, By End User:
- Hospitals
- Clinics
- Homecare setting
Global non-invasive blood glucose monitoring devices Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profile:
- Baxter International Inc.
- Dexcom, Inc
- Abbott
- Medtronic
- Senseonics Holdings, Inc
- GlySens Incorporated
- DiaMonTech GmbH
- Nemaura Medical Inc.
- Integrity Applications, Inc.
- CNOGA Medical Ltd.
- Breath Health, Inc.
- Metamaterial Technologies Inc.
- Opticology Inc.
- NovioSense BV
- Quick LLC
- RSP Systems A/S.

Product Code: CMI1480

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Modality
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
- Restraints
Lack of knowledge and diagnosis
- Opportunities
The growth of veterinary medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
EM Waves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Optical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Enzymatic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Wearable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Non-wearable/Benchtop
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Embedded Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Homecare setting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2031 (%)
- Y-o-Y Growth Analysis, For Country 2020 -2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2019-2031,(US$ Mn)
GCC
Israel
Rest of Middle East
North Africa
Central Africa
South Africa

9. Competitive Landscape

Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dexcom, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Senseonics Holdings, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlySens Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DiaMonTech GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nemaura Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Integrity Applications, Inc.
CNOGA Medical Ltd
Breath Health, Inc.
Metamaterial Technologies Inc.
Opticology Inc.
NovioSense BV
Quick LLC
RSP Systems A/S.
Analyst Views

10. Section

Research Methodology
About us